|Salary:||£35,328 to £42,701 per annum, inclusive of London Allowance|
|Placed On:||20th August 2019|
|Closes:||22nd September 2019|
The appointment will be on UCL Grade 7.
Applicants are invited for a Research Fellow position in a research programme in the cell biology of neurodegeneration caused by mutations in rhodopsin.
The aims of the research are to use patient derived stem cells and CRISPR produced knock-in rodent models to understand the mechanisms of retinal degeneration caused by mutations in rhodopsin and develop potential therapies to treat this incurable blindness.
The post is funded by a Wellcome Trust Investigator award for 3 years in the first instance, and is available from 1 October 2019.
Molecular biology and cell biology and/or experience with stem cell and/or cell and animal models of disease would be an advantage. Applicants must have a PhD in a suitable area. Previous experience, or a good understanding of vision, stem cell biology, and/or rodent physiology is strongly recommended, though individuals without direct experience in these areas, but with exceptional motivation or experience of research in related areas, are also encouraged to apply.
Applicants should apply online. To access further details about the position and how to apply please click on the ‘Apply’ button above.
Please ensure you attach your CV and list of publications. You should also provide a personal statement to support your application.
Please email informal queries to Professor Mike Cheetham Michael.email@example.com.
If you have any enquiries regarding the application process please email: firstname.lastname@example.org.
Latest time for the submission of applications: 23:59.
Interview Date: TBC
UCL Taking Action for Equality
We will consider applications to work on a part-time, flexible and job share basis wherever possible.
Our department holds an Athena SWAN Bronze award, in recognition of our commitment to advancing gender equality.
Type / Role: